🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Simulations Plus director sells shares worth over $23k

Published 10/02/2024, 04:36 AM
SLP
-

Simulations Plus , Inc. (NASDAQ:SLP) Director Daniel L. Weiner has sold a portion of his holdings in the company, according to the latest filing with the Securities and Exchange Commission. The transaction, which took place on September 27, 2024, involved the sale of 750 shares at an average price range of $31.18 to $31.86 per share, resulting in a total value of approximately $23,655.

The reported sale was conducted automatically under a Rule 10b5-1 trading plan, a mechanism that allows company insiders to set up a predetermined schedule for buying or selling stocks at a time when they are not in possession of material non-public information. This allows for planned transactions that comply with insider trading laws.

Following the sale, Weiner's ownership in Simulations Plus stands at 6,994 shares. The company, known for its computer-integrated systems design services, continues to be a player in the tech sector, with Weiner maintaining a significant stake despite the recent sale.

Investors often monitor insider transactions as they can provide insights into the sentiment of company executives and directors regarding the firm's prospects. The sale of shares by Weiner might be of interest to those following the company's stock performance and insider trading activities.

Simulations Plus has not provided any commentary regarding the transaction, and it remains a routine disclosure as part of the regulatory requirements for company insiders. Investors and analysts following Simulations Plus will continue to assess the company's performance and future outlook as part of their investment decision-making process.

In other recent news, Simulations Plus has been making strategic moves to bolster its growth. The company announced a restructuring of its business units and leadership to support expansion, prompted by recent acquisitions. Key personnel changes include the promotion of Steven Chang to President of Quantitative Systems Pharmacology and the appointments of Jenna Rouse and Murry Alper to lead new business units.

Simulations Plus has also been the subject of analyst attention, with KeyBanc assigning an Overweight rating to the company's stock and JMP Securities initiating coverage with a Market Perform rating. Oppenheimer reaffirmed an Outperform rating, expressing confidence in the company's strategic direction and financial outlook.

In terms of financial performance, Simulations Plus reported a 14% increase in third-quarter fiscal year 2024 revenues, reaching $18.5 million. However, the company revised its earnings per share guidance to between $0.46 and $0.48 due to higher-than-anticipated transaction costs. Simulations Plus also discontinued its quarterly cash dividend to prioritize growth investments.

These recent developments indicate a focus on growth and expansion, as well as a positive reception from market analysts.

InvestingPro Insights

To provide additional context to Director Daniel L. Weiner's recent stock sale, it's worth examining some key financial metrics and insights from InvestingPro for Simulations Plus, Inc. (NASDAQ:SLP).

As of the latest data, Simulations Plus boasts a market capitalization of $624.84 million. The company's revenue for the last twelve months as of Q3 2024 stood at $66.98 million, with a notable revenue growth of 20.29% over the same period. This growth trajectory aligns with the company's position in the computer-integrated systems design services sector.

InvestingPro Tips highlight that Simulations Plus holds more cash than debt on its balance sheet, which suggests a strong financial position. This could provide reassurance to investors concerned about the company's ability to weather potential economic headwinds. Additionally, the company has maintained dividend payments for 13 consecutive years, indicating a commitment to shareholder returns despite Director Weiner's recent share sale.

It's important to note that while the stock is trading near its 52-week low, with a price at 60.99% of its 52-week high, the company remains profitable. The P/E ratio (adjusted) for the last twelve months as of Q3 2024 stands at 47.05, which some investors might consider high. This valuation metric, coupled with the InvestingPro Tip that SLP is trading at a high earnings multiple, suggests that the market still has expectations for future growth.

For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for Simulations Plus, providing a deeper dive into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.